Celldex Therapeutics To Present At Upcoming Investor Conferences

2024-11-11 04:16:05

(MENAFN- GlobeNewsWire - Nasdaq) HAMPTON, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that management will participate in fireside chats at two upcoming conferences:

Guggenheim Healthcare Innovation Conference on Tuesday, November 12th at 4:00 p.m. ET

7th Annual Evercore HealthCONx Conference on Tuesday, December 3rd at 4:15 p.m. ET

Live webcasts of the presentations will be available on the "Events & Presentations” page of the "Investors & Media " section of the Celldex website . Replays will be available for 90 days following the event.

About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company leading the science at the intersection of mast cell biology and the development of transformative therapeutics for patients. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with severe inflammatory, allergic, autoimmune and other devastating diseases. Visit

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
...

Patrick Till
Meru Advisors
(484) 788-8560
...

MENAFN11112024004107003653ID1108873783

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.